Logo image
Why is growth more difficult to achieve for biopharmaceutical latecomer firms? Evidence from Taiwan
Journal article   Peer reviewed

Why is growth more difficult to achieve for biopharmaceutical latecomer firms? Evidence from Taiwan

M.C. Hu, W.C. Hsu and C. Y. Wu
Science, Technology & Society Science, Technology & Society
2017

Abstract

biopharmaceutical latecomer firms

Metrics

1 Record Views

Details

Logo image